The financial documents are the first Intermountain has filed since completing a merger with Broomfield, Colo.-based SCL Health in April.
For the six months ended June 30, the 33-hospital system reported revenues of $6.5 billion, up 25 percent from $5.2 billion in the same period a year earlier. The health system’s expenses totaled $5.9 billion in the first half of this year, up 31 percent from $4.5 billion in the first half of 2021.
Intermountain ended the first two quarters of this year with operating income of $288 million, down from $461 million in the same period last year.
After incorporating nonoperating income, including a $4.1 billion contribution from its merger with SCL Health, Intermountain ended the first six months of this year with net income of $2.7 billion. In the first two quarters of 2021, the health system’s net income totaled $1.9 billion.
Intermountain named Lydia Jumonville interim CEO on Aug. 19, about a week after announcing the departure of Marc Harrison, MD. Ms. Jumonville served as president and CEO of SCL Health before the system merged with Intermountain.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
